Our story
We create purpose-driven robots that are engineered to make spaces safer, smarter, and healthier.
Engineered with purpose
Our story began with a pressing challenge: the widening gap between the increasing demands in healthcare facilities and the limited personnel available to support them — all while expectations for safety and efficiency continued to rise. Meeting these needs requires practical, scalable solutions that support staff and optimize operations.
Healthcare-associated infections (HAIs) remain a critical concern within this broader challenge. For example, one in 31 patients acquires an HAI 1, contributing to an estimated $28.4–$45 billion in costs in the U.S annually 2. Additionally, an estimated 136 million cases occur worldwide every year 3.
While preventable, these infections demand solutions that work within the realities of staff and workflow. In response, we developed the ADIBOT A1, a fully autonomous UV-C disinfection robot designed to help facilities reduce infection risk efficiently and reliably.
Though the A1 is our flagship robot, it’s just the beginning. Our vision is to build a range of autonomous solutions that integrate seamlessly into everyday operations while advancing public health.
Over the years, we’ve grown alongside our customers, scaling operations and infrastructure while maintaining unparalleled support. Our technical operations team works hands-on with every facility, ensuring our technology integrates smoothly, adapts effectively, and delivers measurable results.
Robots are what we make. Partnership is how we work.
1 HAI and Antimicrobial Use Prevalence Surveys, 2024
2 Clinical and Economic Burden of Healthcare-AssociatedInfections: A Prospective Cohort Study, 2023
3 Global Incidence in Hospital-Associated Infections Resistant to Antibiotics: An Analysis of Point Prevalence Surveys from 99 Countries, 2023
Healthcare-associated infections (HAIs) remain a critical concern within this broader challenge. For example, one in 31 patients acquires an HAI 1, contributing to an estimated $28.4–$45 billion in costs in the U.S annually 2. Additionally, an estimated 136 million cases occur worldwide every year 3.
While preventable, these infections demand solutions that work within the realities of staff and workflow. In response, we developed the ADIBOT A1, a fully autonomous UV-C disinfection robot designed to help facilities reduce infection risk efficiently and reliably.
Though the A1 is our flagship robot, it’s just the beginning. Our vision is to build a range of autonomous solutions that integrate seamlessly into everyday operations while advancing public health.
Over the years, we’ve grown alongside our customers, scaling operations and infrastructure while maintaining unparalleled support. Our technical operations team works hands-on with every facility, ensuring our technology integrates smoothly, adapts effectively, and delivers measurable results.
Robots are what we make. Partnership is how we work.
1 HAI and Antimicrobial Use Prevalence Surveys, 2024
2 Clinical and Economic Burden of Healthcare-AssociatedInfections: A Prospective Cohort Study, 2023
3 Global Incidence in Hospital-Associated Infections Resistant to Antibiotics: An Analysis of Point Prevalence Surveys from 99 Countries, 2023
We are the good robot
At TGR, we believe robotics should assist—not replace—the essential workforce. That’s why our vision is to expand and continue designing intelligent robots that support people, simplify complex tasks, and get vital work done.
JOIN OUR NEWSLETTER
Email
We never share your information
%2C%20Color%3DNegative.png){kind=small}
